Search Results - "SCHREIBER, Karin"

Refine Results
  1. 1

    Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides by Sharma, Preeti, Marada, Venkata V. V. R., Cai, Qi, Kizerwetter, Monika, He, Yanran, Wolf, Steven P., Schreiber, Karin, Clausen, Henrik, Schreiber, Hans, Kranz, David M.

    “…The potency of adoptive T cell therapies targeting the cell surface antigen CD19 has been demonstrated in hematopoietic cancers. It has been difficult to…”
    Get full text
    Journal Article
  2. 2

    IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner by Liu, Rebecca Berlant, Engels, Boris, Schreiber, Karin, Ciszewski, Cezary, Schietinger, Andrea, Schreiber, Hans, Jabri, Bana

    “…A major challenge of cancer immunotherapy is the persistence and outgrowth of subpopulations that lose expression of the target antigen. IL-15 is a potent…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors by Schreiber, Karin, Karrison, Theodore G, Wolf, Steven P, Kiyotani, Kazuma, Steiner, Madeline, Littmann, Eric R, Pamer, Eric G, Kammertoens, Thomas, Schreiber, Hans, Leisegang, Matthias

    Published in Cancer immunology research (01-02-2020)
    “…Burnet postulated that the diversity of T-cell receptors (TCR) allows T cells to protect against the development of cancers that display antigens with a…”
    Get more information
    Journal Article
  5. 5

    Densely Granulated Murine NK Cells Eradicate Large Solid Tumors by LIU, Rebecca B, ENGELS, Boris, JABRI, Bana, SCHREIBER, Hans, ARINA, Ainhoa, SCHREIBER, Karin, HYJEK, Elizabeth, SCHIETINGER, Andrea, BINDER, David C, BUTZ, Eric, KRAUSZ, Thomas, ROWLEY, Donald A

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Natural killer (NK) cells inhibit early stages of tumor formation, recurrence, and metastasis. Here, we show that NK cells can also eradicate large solid…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography by Ibrahim, Tareq, Nekolla, Stephan G., Schreiber, Karin, Odaka, Kenichi, Volz, Stefan, Mehilli, Julinda, Güthlin, Martin, Delius, Wolfram, Schwaiger, Markus

    “…The study compared flow reserve indices by magnetic resonance imaging (MRI) with quantitative measures of coronary angiography and positron emission tomography…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase by Schietinger, Andrea, Philip, Mary, Liu, Rebecca B, Schreiber, Karin, Schreiber, Hans

    Published in The Journal of experimental medicine (25-10-2010)
    “…Cancers frequently evade cytotoxic T lymphocyte-mediated destruction through loss or down-regulation of tumor antigens and antigen-presenting major…”
    Get full text
    Journal Article
  11. 11

    One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication by Wolf, Steven P, Anastasopoulou, Vasiliki, Drousch, Kimberley, Diehl, Markus I, Engels, Boris, Yew, Poh Yin, Kiyotani, Kazuma, Nakamura, Yusuke, Schreiber, Karin, Schreiber, Hans, Leisegang, Matthias

    Published in Clinical cancer research (15-04-2024)
    “…To achieve eradication of solid tumors, we examined how many neoantigens need to be targeted with how many T-cell receptors (TCR) by which type of T cells…”
    Get full text
    Journal Article
  12. 12

    Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation by Leisegang, Matthias, Engels, Boris, Schreiber, Karin, Yew, Poh Yin, Kiyotani, Kazuma, Idel, Christian, Arina, Ainhoa, Duraiswamy, Jaikumar, Weichselbaum, Ralph R, Uckert, Wolfgang, Nakamura, Yusuke, Schreiber, Hans

    Published in Clinical cancer research (01-06-2016)
    “…Cancers usually contain multiple unique tumor-specific antigens produced by single amino acid substitutions (AAS) and encoded by somatic nonsynonymous single…”
    Get full text
    Journal Article
  13. 13

    Tracking the Common Ancestry of Antigenically Distinct Cancer Variants by SCHREIBER, Karin, WU, Terry H, KAST, W. Martin, SCHREIBER, Hans

    Published in Clinical cancer research (01-03-2001)
    “…In the months and years after first diagnosis, cancers often show an increase in their malignancy such as faster growth, resistance to chemo- and/or hormonal…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    E-102 Destruction of the tumor microenvironment by neoantigen-specific T cells prevents relapse of therapy-resistant cancer variants by Wolf, Steven, Schreiber, Karin, Steiner, Madeline, Weichselbaum, Ralph, Leisegang, Matthias, Schreiber, Hans

    “…Microorganisms frequently escape host defenses by generating heritable variants. Cancer cells replicate more slowly than most microorganisms, but variants…”
    Get full text
    Journal Article
  15. 15

    Abstract 3238: Engineering chimeric antigen receptors for adoptive T cell therapy of cancers that express the Tn antigen by Sharma, Preeti, Marada, Venkata VVR, Kizerwetter, Monika, Schane, Claire P., He, Yanran, Wolf, Steven P., Schreiber, Karin, Roy, Edward J., Clausen, Henrik, Schreiber, Hans, Kranz, David M.

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Chimeric antigen receptors (CARs) have shown remarkable promise in treating hematological malignancies, especially those expressing CD19 antigen. On the other…”
    Get full text
    Journal Article
  16. 16

    Abstract 3587: TCR-transduced T cells targeting a truncal mutation caused by a nsSNV destroy large solid tumors despite intratumoral genetic heterogeneity by Leisegang, Matthias, Schreiber, Karin, Wolf, Steven P., Anastosopolou, Vasiliki, Borutta, Kimberley, Yew, PohYin, Kiyotani, Kazuma, Nakamura, Yusuke, Schreiber, Hans

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Most if not all cancers have individually specific, so-called unique antigens that we discovered in 1995 to be caused by somatic tumor-specific, non-synonymous…”
    Get full text
    Journal Article
  17. 17
  18. 18

    CD4 + T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy by Wolf, Steven P, Leisegang, Matthias, Steiner, Madeline, Wallace, Veronika, Kiyotani, Kazuma, Hu, Yifei, Rosenberger, Leonie, Huang, Jun, Schreiber, Karin, Nakamura, Yusuke, Schietinger, Andrea, Schreiber, Hans

    Published in Science immunology (13-09-2024)
    “…Cancers eventually kill hosts even when infiltrated by cancer-specific T cells. We examined whether cancer-specific T cell receptors of CD4 T cells (CD4TCRs)…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication by Arina, Ainhoa, Karrison, Theodore, Galka, Eva, Schreiber, Karin, Weichselbaum, Ralph R, Schreiber, Hans

    Published in Cancer immunology research (01-02-2017)
    “…Adoptively transferred CD8 T cells can stabilize the size of solid tumors over long periods of time by exclusively recognizing antigen cross-presented on tumor…”
    Get more information
    Journal Article